Streetbeat News

TNON

Tenon Medical, Inc.

https://www.tenonmed.com

Industry

Medical - Devices

Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was founded in 2012 and is based in Los Gatos, California.

Open

4.29

Mkt cap

13M

Volume

246M

High

5.85

P/E Ratio

0.01

52-wk high

15.79

Low

3.27

Div yield

N/A

52-wk low

0.91

Numerous companies are scheduled to report their earnings on March 12, 2024, with expectations ranging from significant profits to losses. Key highlights include Aurora Mobile, MINISO Group, and Archer-Daniels Midland among others, projecting varied financial outcomes for their respective quarters.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 9:35 am

Tenon Medical (NASDAQ:TNON) is scheduled to release its quarterly earnings report on 2024-03-12, with an estimated EPS of $-1.38. Analysts and investors will be looking for an earnings beat and positive guidance for the next quarter. Historically, Tenon Medical has had mixed results in beating EPS estimates, with share price reactions varying. The stock has experienced a significant decline over the last year, trading at $1.33 as of March 08, down 94.3% over the 52-week period.

Portfolio Pulse from Benzinga Insights

March 11, 2024 | 5:00 pm

Tenon Medical, Inc. (TNON) announced the issuance of a Notice of Allowance from the USPTO for a patent application enhancing claims for its Catamaran SI Joint implant. This addition to Tenon's patent portfolio, which includes 8 issued patents and 23 pending applications, underscores the company's commitment to protecting its innovative sacroiliac joint treatment technologies.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 1:13 pm

Tenon Medical has successfully raised approximately $2.6 million through a Series A Preferred Stock offering. The company used part of the proceeds to retire $1.25 million in secured debt.

Portfolio Pulse from Benzinga Newsdesk

February 21, 2024 | 1:06 pm

In Wednesday's after-market session, several healthcare stocks showed notable movements. KalVista Pharma, Anitra, CytoMed Therapeutics, Vaccinex, Universe Pharmaceuticals, and Cidara Therapeutics were among the gainers, with increases ranging from 6.55% to 11.0%. On the losing side, Adaptive Biotechnologies, Beyond Air, Tenon Medical, Ontrak, Panbela Therapeutics, and Acutus Medical saw declines between 6.57% and 8.6%, with Adaptive Biotechnologies' drop attributed to its Q4 earnings release.

Portfolio Pulse from Benzinga Insights

February 14, 2024 | 9:31 pm

Tenon Medical has announced the second adjournment of its special meeting of stockholders, which is now scheduled for January 30, 2024. The reason for the adjournment or the agenda for the meeting has not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 10:03 pm

Tennon Medical's stock price has increased following the company's filing of a U.S. Patent Application for 'Systems For Sacroiliac (SI) Joint Stabilization'.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 8:21 pm

Tenon Medical has filed a U.S. patent application (No. 20230404762) for systems related to sacroiliac (SI) joint stabilization. The patent application is a significant step in the company's efforts to innovate in the medical device sector, specifically targeting treatments for conditions related to the SI joint.

Portfolio Pulse from Charles Gross

December 21, 2023 | 11:29 am

Tenon Medical, Inc. (NASDAQ:TNON) has announced its participation in two immersive webinar physician training programs featuring its Catamaran SI Joint Fusion System. The training, led by Dr. Matthew Davies, reached approximately 60 health care providers and focused on the system's clinical use, patient selection, procedural outcomes, and the advantages of the Catamaran Fixation Device. The company emphasizes its commitment to professional education and training for health care providers.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 1:34 pm

Genesco Inc. shares fell by approximately 20% following their quarterly results. The article also lists other stocks that moved significantly in Friday's mid-day session, categorizing them as gainers and losers. Notable gainers include Harbor Custom Development, Altimmune, and Elastic N.V., which rose due to positive trial results, financial results, and guidance, respectively. Among the losers, Polar Power experienced a significant drop after pricing a public offering, and Ampio Pharmaceuticals fell after a previous surge. The article provides a snapshot of the mid-day stock movements, highlighting the volatility and market reactions to company-specific news and broader market trends.

Portfolio Pulse from Lisa Levin

December 01, 2023 | 5:04 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.